期刊文献+

白细胞介素-27在小鼠病毒性心肌炎中的表达 被引量:2

Expressions of IL-27 in the coxsackievirus B3-induced mice viral myocarditis
原文传递
导出
摘要 目的:研究小鼠病毒性心肌炎(VMC)模型中白细胞介素(IL)-27基因和蛋白的表达,探究其在VMC发病中的作用及意义。方法:VMC组用柯萨奇病毒B3(CVB3)感染Balb/c小鼠建立VMC模型,注射100TCID 50病毒液0.1ml;对照组注射等量磷酸盐缓冲液(PBS)。在注射后的第0、1、2、3、4和6周应用逆转录-聚合酶链反应检测两组小鼠心肌组织中IL-27亚基p28及EBI3的mRNA表达,酶联免疫双夹心抗体法检测血清中IL-27蛋白的表达。结果:与对照组比较,VMC组小鼠心肌组织中IL-27p28mRNA水平自第1周开始升高,第2周时达峰值,并至少维持至第6周(均P〈0.05);VMC组第1~6周各时点血清IL-27蛋白均明显高于对照组(均P〈0.05);与对照组同时点比较,VMC组各时点小鼠心肌组织中IL-27EBI3mRNA差异均无统计学意义。结论:IL-27在VMC小鼠中高表达,提示IL-27可能参与VMC的发病机制。 Objective:To investigate the expression of interleukin-27(IL-27)in the coxsackievirus B3-induced mice viral myocarditis(VMC).Method:BALB/c mice were intraperitoneally infected with CVB 3for establishing VMCmodels.Control mice were treated with phosphate-buffered saline(PBS).On 0,1,2,3,4,6week after injection,expressions of serum IL-27were analyzed by enzyme linked immosorbent assay(ELISA).Productions of cardiac IL-27p28and EBI3mRNA were measured by real time-polymerase chain reaction(RT-PCR).Result: Levels of cardiac IL-27p28mRNA obviously increased in VMC mice on week 1after infection,peaked on week 2, and highly persisted to at least week 6(all P0.05).Compared with control group,serum IL-27protein was higher in VMC group from week 1to week 6(all P0.05).There was no significant difference production of cardiac IL-27EBI3mRNA was found between VMC and control group throughout the course of the experiment.Conclusion:The increased levels of IL-27may play an important role in the pathogenesis of CVB3-induced mice VMC.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2014年第2期110-113,共4页 Journal of Clinical Cardiology
基金 国家自然科学基金资助项目(No:81160032)
关键词 病毒性心肌炎 白细胞介素-27 viral myocarditis interleukin-27
  • 相关文献

参考文献10

  • 1吴红霞,刘嫣方,胡辰晨,苏兆亮.IL-27对实验性自身免疫性心肌炎的干预作用研究[J].新医学,2011,42(12):833-835. 被引量:7
  • 2DeLisa Fairweather,Katelyn A. Stafford,Yoon K. Sung.Update on coxsackievirus B3 myocarditis[J].Current Opinion in Rheumatology.2012(4)
  • 3Christopher A. Hunter,Rob Kastelein.Interleukin-27: Balancing Protective and Pathological Immunity[J].Immunity.2012(6)
  • 4Marek Jankowski,Piotr Kopiński,Anna Goc.Interleukin-27: Biological Properties and Clinical Application[J].Archivum Immunologiae et Therapiae Experimentalis.2010(6)
  • 5DeLisa Fairweather,Noel R. Rose.Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicity[J].Methods.2006(1)
  • 6Jie Sun,Haley Dodd,Emily K Moser,Rahul Sharma,Thomas J Braciale.CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs[].Nature Immunology.2011
  • 7Yang Fan,Wu Weifeng,Yan Yuluan,Kong Qing,Pang Yu,Huang Yanlan.Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation[].Virology Journal.2011
  • 8Kong Qing,Wu Weifeng,Yang Fan,Yan Yuluan,Pang Yu,Huang Yanlan.Distinct different expression of Th17 and Th9 cells in coxsackie virus B3-induced mice viral myocarditis[].Virology Journal.2011
  • 9Cooper LT Jr.Myocarditis[].The New England Journal of Medicine.2009
  • 10Astrid C. Frank,Xiaozhen Zhang,Antonios Katsounas.Interleukin-27, an Anti-HIV-1 Cytokine, Inhibits Replication of Hepatitis C Virus[].JOURNAL OF INTERFERON AND CYTOKINE RESEARCH.2010

二级参考文献6

  • 1CIHAKOVA D, ROSE N R. Pathogenesis of myocarditis and dilated cardiomyopathy [ J ]. Adv Immunol, 2008, 99 : 95-114,.
  • 2YUAN J, YU M, LIN Q W, et al. Thl7 cells contribute to viral replication in coxsackievirus B3-induced acute vi- ral myocarditis [J] . J Immunol, 2010, 185 (7): 4004-4010.
  • 3ROSE N R. Immune-mediated heart disease: in the foot- steps of Jenner [ J]. Autoimmunity, 2001, 34 (3) : 159-160.
  • 4YOSHIDA H, YOSHIYUKI M. Regulation of immune re- sponses by interleukin-27 [ J ] . Immuno| Rev, 2008,226: 234-247.
  • 5STUMHOFER J S, HUNTER C A. Advances in under- standing the anti-inflammatory properties of IL-27 [ J ]. Immunol Lett, 2008, 117 (2):123-130.
  • 6AWASTHI A, CARRIER Y, PERON J P, et al. A dom- inant function for interleukin 27 in generating interleukin lO-producing anti-iifflammatory T cells [ J ]. Nat Immu- nol. 2007, 8 (12): 1380-1309.

共引文献6

同被引文献26

  • 1于波,侯静波,吕航.苏木提取物对心脏移植大鼠T淋巴细胞亚群的免疫抑制和对心肌的保护作用[J].中国地方病学杂志,2004,23(6):539-542. 被引量:12
  • 2金鹏,周亚滨,宋琦,郑佳新,李学奇.苏木有效成分免疫抑制作用的实验研究[J].中药材,2007,30(2):196-200. 被引量:19
  • 3JOSEPH W CARL, JR, XUE -FENG BAI. IL27: Its Roles in the Induction and Inhibition of Inflammation. Int J Clin Exp Pathol, 2008, 1(2) : 117 -123.
  • 4HIBBERT L, PFLANZ S, DE WAAL MALEFYT R et al. IL - 27 and IFN - alphasigual via Statl and Stat3 and induce T - Bet and IL- 12R beta2 in naive T cells[ J] . J Interferon Cytokine Res, 2003, 23(9) :513 -522.
  • 5GUO M,MAO X,JIQ. Inhibition of IFN regulatory factor- 1 down -regulate Thl cell function in patients with acute coronary syn- drome [J]. J Clin Immunol,2010,20:241 -252.
  • 6DIMITRY A, CHISTIAKOVA,IGOR A,SOBEN1NB, et al. Regu- latory T cells in athemsclerosis and strategies to induce the endoge- nous athemprotective immune response[ J ]. Immunol Lett, 2013.
  • 7TETSUAKI HIRASE1, HIROMITSU HARA, YOSHIYUKI MIYAZAKI, NORIKO IDE1, et al. Interleukin 27 inhibits athero- sclerosis via immunoregulation of macrophages in mice ,2013.
  • 8POT C, APETOH L, AWASTHI A. Induction of regulatory Trl cells and inhibition of Thl7 ceils by IL -27 [ J]. Semin Immuno1,2011, 23:438 - 445.
  • 9CHRISTIAN STUMPF, CHRISTOPH LEHNER, ATILLA YILMAZ et al. Decrease of serum levels of theanti - inflammatory cytokine interleukin - 10 inpatients with advanced chronic heart failure. Clinical Science,2003, 105 : 45 -50.
  • 10HAZEBROEK M, DENNERT R, HEYMANS S. Idiopathic dilated- cardiomyopathypossible triggers and treatment strategies [ J ]. Neth Heart J,2012,20(7 - 8 ) :332 - 335.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部